Skip to content

Safety and Efficacy of Transverse Mesocolic Partitioning for the Prevention of Major Complications Following Pancreatectomy

Safety and Efficacy of Transverse Mesocolic Partitioning for the Prevention of Major Complications Following Pancreatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127396
Enrollment
Unknown
Registered
2026-06-30
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clinically relevant postoperative pancreatic fistula

Interventions

Transverse mesocolic sequestration technique:None
Conventional pancreatic reconstruction or standard pancreatic stump management without transverse mesocolic sequestration:None

Sponsors

Sun Yat-sen Memorial Hospital Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 75, any gender. 2. Pathologically confirmed as benign or low-grade malignant pancreatic tumors (like NET, IPMN, SCN, MCN, SPN) or chronic pancreatitis. 3. Undergoing function-preserving pancreatic surgeries such as DPPHR, MP, SPDP, etc. 4. Complete perioperative clinical data and follow-up records for at least 3 months after surgery.

Exclusion criteria

Exclusion criteria: 1.Patients with pancreatic ductal adenocarcinoma (PDAC) confirmed by preoperative imaging or intraoperative exploration who required radical resection. 2.Patients with severe preoperative coagulation disorders or long-term use of anticoagulant therapy. 3.Patients with a history of major upper abdominal surgery resulting in intra-abdominal adhesions or destruction of the transverse mesocolon anatomy. 4.Patients who were lost to follow-up or refused to provide relevant data for non-technical reasons.

Design outcomes

Primary

MeasureTime frame
Incidence of clinically relevant postoperative pancreatic fistula (CR-POPF);

Secondary

MeasureTime frame
Occurrence rates and severity distribution of CR-POPF in two groups;

Countries

China

Contacts

Public ContactZhang Rui

Sun Yat-sen Memorial Hospital Sun Yat-sen University

13828409500@126.com+86 20 8133 2587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026